SCHEMBL12333877

SCHEMBL12333877

CC1(C)c2cc(-c3ccc(N)cc3)ccc2-c2ccc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 2/20 0.42
▸ KDM4E B2RXH2 3/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ ALDH1A1 P00352 5/20 0.35
▸ MEN1 O00255 4/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ MAPT P10636 3/20 0.35
▸ HTT P42858 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HBB P68871 1/20 0.35
▸ TDP2 O95551 1/20 0.33
▸ IL1R1 P14778 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12306526 0.93 KDM4E (0.46) PDK2KDM4EL3MBTL1ATMHDAC4
SCHEMBL12306587 0.91 L3MBTL1 (0.47) PDK2KDM4EL3MBTL1ATMHDAC4
SCHEMBL12414494 0.91 KDM4E (0.43) PDK2KDM4EL3MBTL1ATMHDAC4
SCHEMBL12306583 0.89 KDM4E (0.42) PDK2KDM4EL3MBTL1ATMHDAC4
SCHEMBL13382211 0.89 KDM4E (0.42) PDK2KDM4EL3MBTL1ATMHDAC4
SCHEMBL22237673 0.88 PDK2 (0.34) PDK2KDM4EL3MBTL1ATMHDAC4
SCHEMBL20232324 0.88 KDM4E (0.41) PDK2KDM4EL3MBTL1ATMHDAC4
SCHEMBL18777955 0.88 KDM4E (0.41) PDK2KDM4EL3MBTL1ATMHDAC4
SCHEMBL24729769 0.88 KDM4E (0.43) PDK2KDM4EL3MBTL1ATMHDAC4
SCHEMBL29850305 0.88 KDM4E (0.43) PDK2KDM4EL3MBTL1ATMHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8013160-B2 Fluorene-based derivative and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2011-09-06 — — US disclosed
US-20100277063-A1 FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-11-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100277063-A1 FLUORENE-BASED DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME LEF1, FLNA, AFF2 PDK2 1028/4885KDM4E 1471/4885L3MBTL1 816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback